MSM/12
Meeting of the Member State mechanism on substandard and falsified medical products
A/MSM/12
List of participants – Liste des Délégués
A/MSM/12/1
Provisional agenda
A/MSM/12/1 (annotated)
Provisional agenda (annotated)
A/MSM/12/2
Update on the activities and budget to implement the workplan of the Member State mechanism
A/MSM/12/3
Update on incidents of over-the-counter syrups for children with confirmed or suspected contamination with high levels of diethylene glycol and ethylene glycol
A/MSM/12/4
Updates on the list of prioritized activities for the period 2022–2023
A/MSM/12/5
Identification of reporting barriers faced by national focal points of the Global Focal Point Network and possible solutions
Executive summary linked to Activity B
A/MSM/12/6
Updates on the list of prioritized activities for the period 2022–2023
Substandard and falsified medical products and informal markets
Executive summary of literature review linked to Activity H
A/MSM/12/7
Governance matters
Decision-making of the Member State mechanism
A/MSM/12/8
Governance matters
Possible engagement with non-State actors in the work of the Member State mechanism
A/MSM/12/9
Draft list of prioritized activities to implement the workplan of the Member State mechanism for the period 2024–2025
Updated following the Steering Committee meeting in June 2023
A/MSM/12/10
Report of the twelfth meeting of the Member State mechanism on substandard and falsified medical products
